Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1181-1190 of 1,298) with videos related to

Pageof 130
Sort By:
Journal of Inherited Metabolic Disease|March 3, 2017
Expanding the phenotype in argininosuccinic aciduria: need for new therapiesJulien Baruteau, Elisabeth Jameson, Andrew A Morris, et al.
Nature Communications|June 18, 2015
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumoursTan A Ince, Aurea D Sousa, Michelle A Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2016
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel TherapeuticsJoyce F Liu, Sangeetha Palakurthi, Qing Zeng, et al.
Cell|October 15, 2013
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cellsWilliam J Israelsen, Talya L Dayton, Shawn M Davidson, et al.
Future Oncology (London, England)|October 8, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancerCharles D Lopez, Adel Kardosh, Emerson Y Chen, et al.
NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
The Journal of Clinical Investigation|December 16, 2025
Patient-Derived Xenograft Models of Fanconi Anemia-Associated Head and Neck Cancer Identify Personalized Therapeutic StrategiesJennifer Grandis, Hua Li, Benjamin A Harrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
Brain : a Journal of Neurology|March 20, 2014
Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcomePhilippa B Mills, Stephane S M Camuzeaux, Emma J Footitt, et al.
Pageof 130

Showing results (1181-1190 of 1,298) with videos related to

Sort By:
Pageof 130
Journal of Inherited Metabolic Disease|March 3, 2017
Expanding the phenotype in argininosuccinic aciduria: need for new therapiesJulien Baruteau, Elisabeth Jameson, Andrew A Morris, et al.
Nature Communications|June 18, 2015
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumoursTan A Ince, Aurea D Sousa, Michelle A Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2016
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel TherapeuticsJoyce F Liu, Sangeetha Palakurthi, Qing Zeng, et al.
Cell|October 15, 2013
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cellsWilliam J Israelsen, Talya L Dayton, Shawn M Davidson, et al.
Future Oncology (London, England)|October 8, 2024
CASPER: A Phase I trial combining calaspargase pegol-mnkl and cobimetinib in pancreatic cancerCharles D Lopez, Adel Kardosh, Emerson Y Chen, et al.
NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
The Journal of Clinical Investigation|December 16, 2025
Patient-Derived Xenograft Models of Fanconi Anemia-Associated Head and Neck Cancer Identify Personalized Therapeutic StrategiesJennifer Grandis, Hua Li, Benjamin A Harrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast CancerMelinda L Telli, Kirsten M Timms, Julia Reid, et al.
Brain : a Journal of Neurology|March 20, 2014
Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcomePhilippa B Mills, Stephane S M Camuzeaux, Emma J Footitt, et al.
Pageof 130